Gt Biopharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.44

+0.01 (+2.33%)

As of Jun 29, 10:38 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +5,547.7% upside

Low Target $15.48

Average Target $24.85

High Target $31.61

Current Price $0.44

Current
$0.44

Target
$24.85

$15.48 $24.85 avg $31.61

Scenario Analysis

Bear Case

$15.48

3,418.2%

Low target

Base Case

$24.85

+5,547.7%

Avg target

Bull Case

$31.61

+7,084.1%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$3.85

-88.6% from high

52-Week Low

$0.26

+68.6% from low

Target vs 52W High

$24.85

+545.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%